G1 Therapeutics Inc
Change company Symbol lookup
Select an option...
GTHX G1 Therapeutics Inc
EXP Eagle Materials Inc
PLAB Photronics Inc
ET Energy Transfer LP
PKG Packaging Corp of America
EQC Equity Commonwealth
EPD Enterprise Products Partners LP
JCI Johnson Controls International PLC
RYT Invesco S&P 500® Equal Weight Technology ETF
SIRI Sirius XM Holdings Inc
Go

Health Care : Biotechnology | Company profile

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.

Postmarket

Last Trade
Delayed
$24.62
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$24.62
Day's Change
-2.52 (-9.29%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
27.19
Day's Low
23.74
Volume
(Heavy Day)
Volume:
497,172

10-day average volume:
383,335
497,172
  • Prev Close
    27.14
  • Today's Open
    27.19
  • Day's Range
    23.74-27.19
  • Avg Vol (10-day)
    383.3K
  • Last (time)
    4:00p ET 07/16/19
  • Last (size)
    466
  • 52-Wk Range
    13.87 - 69.57
    LowHigh
  • (09/11/18 - 03/25/19)
    77.51%
  • 89.8%
  • Market Cap
    922.4M
  • Shares Outstanding
    37.5M
  • -2.51
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 90.77
  • (% of float 06/28/19)
    10.82

Latest News

June 19, 2019
1:58 pm ET
MarketWatch
June 18, 2019
6:00 am ET
Globe Newswire
June 14, 2019
7:01 am ET
Globe Newswire
June 13, 2019
7:01 am ET
Globe Newswire
June 11, 2019
7:00 am ET
Globe Newswire
June 01, 2019
4:00 pm ET
Globe Newswire
May 29, 2019
8:30 am ET
PR Newswire
May 16, 2019
7:01 am ET
Globe Newswire
May 13, 2019
7:01 am ET
Globe Newswire
May 09, 2019
4:02 pm ET
Globe Newswire
May 02, 2019
7:00 am ET
Globe Newswire
May 01, 2019
8:50 am ET
PR Newswire
April 29, 2019
5:07 pm ET
MarketWatch
4:01 pm ET
Globe Newswire
January 23, 2019
7:29 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.